Azenta Inc (AZTA)
52.09
-0.45
(-0.86%)
USD |
NASDAQ |
Apr 24, 16:00
52.12
+0.03
(+0.06%)
After-Hours: 20:00
Azenta Cash from Financing (TTM): -452.51M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -452.51M |
September 30, 2023 | -844.08M |
June 30, 2023 | -675.47M |
March 31, 2023 | -504.43M |
December 31, 2022 | -559.80M |
September 30, 2022 | -62.76M |
June 30, 2022 | -68.97M |
March 31, 2022 | -76.05M |
December 31, 2021 | -25.43M |
September 30, 2021 | -25.91M |
June 30, 2021 | -26.89M |
March 31, 2021 | -26.88M |
December 31, 2020 | -27.08M |
September 30, 2020 | -27.02M |
June 30, 2020 | -522.54M |
March 31, 2020 | -524.67M |
December 31, 2019 | -530.68M |
September 30, 2019 | -191.16M |
June 30, 2019 | 303.65M |
March 31, 2019 | 306.31M |
December 31, 2018 | 311.52M |
September 30, 2018 | 170.28M |
June 30, 2018 | 170.51M |
March 31, 2018 | 171.10M |
December 31, 2017 | 171.25M |
Date | Value |
---|---|
September 30, 2017 | -25.92M |
June 30, 2017 | -25.78M |
March 31, 2017 | -26.18M |
December 31, 2016 | -26.11M |
September 30, 2016 | -25.96M |
June 30, 2016 | -34.46M |
March 31, 2016 | -33.95M |
December 31, 2015 | -34.01M |
September 30, 2015 | -34.01M |
June 30, 2015 | -29.02M |
March 31, 2015 | -27.49M |
December 31, 2014 | -25.93M |
September 30, 2014 | -24.46M |
June 30, 2014 | -19.64M |
March 31, 2014 | -19.61M |
December 31, 2013 | -19.56M |
September 30, 2013 | -19.48M |
June 30, 2013 | -19.39M |
March 31, 2013 | -19.35M |
December 31, 2012 | -19.37M |
September 30, 2012 | -19.25M |
June 30, 2012 | -19.38M |
March 31, 2012 | -14.10M |
December 31, 2011 | -9.007M |
September 30, 2011 | -3.822M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-844.08M
Minimum
Sep 2023
303.65M
Maximum
Jun 2019
-256.25M
Average
-76.05M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Bruker Corp | -193.40M |
Harvard Bioscience Inc | -12.13M |
Bionano Genomics Inc | 113.82M |
Akoya Biosciences Inc | 56.84M |
Singular Genomics Systems Inc | 0.696M |